BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11725909)

  • 1. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
    Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
    Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
    Singh NP; Mandal SK; Thakur A; Kapoor D; Anuradha S; Prakash A; Kohli R; Agarwal SK
    Ren Fail; 2003 Mar; 25(2):255-66. PubMed ID: 12739832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
    Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
    J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
    Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
    J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis.
    Cruciani M; Mengoli C; Serpelloni G; Mazzi R; Bosco O; Malena M
    Vaccine; 2007 Jan; 25(4):709-18. PubMed ID: 16963165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients.
    Anandh U; Bastani B; Ballal S
    Am J Nephrol; 2000; 20(1):53-6. PubMed ID: 10644869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.
    Overton ET; Kang M; Peters MG; Umbleja T; Alston-Smith BL; Bastow B; Demarco-Shaw D; Koziel MJ; Mong-Kryspin L; Sprenger HL; Yu JY; Aberg JA
    Vaccine; 2010 Aug; 28(34):5597-604. PubMed ID: 20600512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.
    Verkade MA; van de Wetering J; Klepper M; Vaessen LM; Weimar W; Betjes MG
    Kidney Int; 2004 Aug; 66(2):614-21. PubMed ID: 15253714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Fabrizi F; Ganeshan SV; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte macrophage colony stimulating factor augmented hepatitis B vaccine protocol for rapid seroprotection in voluntary kidney donors.
    Krishnamurthy K; John GT; Abraham P; Jacob CK
    Indian J Med Res; 2004 Apr; 119(4):162-4. PubMed ID: 15147122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis B vaccination in haemodialysis patients.
    Hess G; Kreiter F; Kösters W; Deusch K
    J Viral Hepat; 1996 May; 3(3):149-53. PubMed ID: 8871874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on rhGM-CSF as adjuvant in revaccination among adults of non-and hyporesponders to hepatitis B vaccine].
    Chen HX; Wang XY; Wang SQ; He HT; Luo XG; Chen XG; Lin CS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):177-9. PubMed ID: 20104770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
    Sasaki Md; Foccacia R; de Messias-Reason IJ
    Vaccine; 2003 Nov; 21(31):4545-9. PubMed ID: 14575766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
    Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
    Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme?
    Wang RX; Boland G; Guo Y; Lei SP; Yang CH; Chen J; Tian J; Wen JY; Du KH; van Hattum J; de Gast GC
    World J Gastroenterol; 2003 Oct; 9(10):2353-5. PubMed ID: 14562411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
    el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
    Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
    Chaves SS; Daniels D; Cooper BW; Malo-Schlegel S; Macarthur S; Robbins KC; Kobetitsch JF; McDaniel A; D'Avella JF; Alter MJ
    Vaccine; 2011 Dec; 29(52):9618-23. PubMed ID: 22044739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune effects of three different programs for revaccination among adults of non- and hypo-responders to hepatitis B vaccine].
    Lin CS; Wang XY; Chen HX; Lee WH; He HT; Gao ZL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):37-40. PubMed ID: 19534878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.